Provided by Tiger Fintech (Singapore) Pte. Ltd.

Iovance Biotherapeutics, Inc.

3.56
-0.0700-1.93%
Pre-market: 3.46-0.1000-2.81%06:01 EDT
Volume:8.33M
Turnover:29.74M
Market Cap:1.17B
PE:-2.77
High:3.64
Open:3.59
Low:3.51
Close:3.63
Loading ...

Iovance Biotherapeutics call volume above normal and directionally bullish

TIPRANKS
·
16 Nov 2024

TD Cowen Sticks to Its Buy Rating for Iovance Biotherapeutics (IOVA)

TIPRANKS
·
14 Nov 2024

Iovance Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
13 Nov 2024

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year

Simply Wall St.
·
09 Nov 2024

IOVA Posts Narrower-Than-Expected Q3 Loss, Amtagvi Sales Drive Top line

Zacks
·
08 Nov 2024

Stock Track | Iovance Stock Plummets Despite Solid Q3 Results and Outlook

Stock Track
·
08 Nov 2024

Iovance Biotherapeutics Shares Down 15% After Q3 Results

THOMSON REUTERS
·
08 Nov 2024

Iovance Biotherapeutics Inc (IOVA) Q3 2024 Earnings Call Highlights: Surpassing Revenue ...

GuruFocus.com
·
08 Nov 2024

Stock Track | Iovance Stock Plunges Despite Strong Q3 Results and Positive Updates

Stock Track
·
08 Nov 2024

Iovance Biotherapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
08 Nov 2024

Iovance falls 12% despite Q3 beats; reaffirms 2024 revenue guidance

seekingalpha
·
08 Nov 2024

Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
08 Nov 2024

Iovance Biotherapeutics: Q3 Earnings Snapshot

Associated Press Finance
·
08 Nov 2024

Stock Track | Iovance Stock Plunges After-Hours Despite Strong Amtagvi Launch and Guidance Reaffirmation

Stock Track
·
08 Nov 2024

Iovance Biotherapeutics Q3 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $58.555M Beat $53.808M Estimate

Benzinga
·
08 Nov 2024

BRIEF-Iovance Biotherapeutics Q3 Net Income USD -83.541 Million

Reuters
·
08 Nov 2024